Safety and Efficacy of Ruxolitinib in an Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (MF): An 1144-Patient Update

被引：0

作者：

Martino, Bruno ^{[1
]}

le Coutre, Philipp ^{[2
]}

Griesshammer, Martin ^{[3
]}

Illmer, Thomas ^{[4
]}

Schlag, Rudolf

Waller, Cornelius F. ^{[5
]}

Liberati, Anna Marina ^{[6
]}

Schafhausen, Philippe ^{[7
]}

Tavares, Renato S. ^{[8
]}

Vannucchi, Alessandro M. ^{[9
]}

Giraldo, Pilar ^{[10
,11
]}

Foltz, Lynda M. ^{[12
]}

Raanani, Pia ^{[13
]}

Gupta, Vikas ^{[14
]}

Tannir, Bayane ^{[15
]}

Ronco, Julian Perez ^{[15
]}

Ghosh, Jaggannath ^{[16
]}

Al-Ali, Haifa Kathrin ^{[17
]}

机构：

[1] Osped Bianchi Melacrino Morelli, Reggio Di Calabria, Italy

[2] Charite, D-13353 Berlin, Germany

[3] Johannes Wesling Clin, Minden, Germany

[4] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany

[5] Univ Hosp Freiburg, Freiburg, Germany

[6] AO S Maria di Terni, Terni, Italy

[7] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[8] Univ Fed Goias, Goiania, Go, Brazil

[9] Univ Florence, Florence, Italy

[10] Miguel Servet Univ Hosp, Zaragoza, Spain

[11] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Zaragoza, Spain

[12] Univ British Columbia, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada

[13] Rabin Med Ctr, Petah Tiqwa, Israel

[14] Princess Margaret Canc Ctr, Toronto, ON, Canada

[15] Novartis Pharma AG, Basel, Switzerland

[16] Novartis Pharmaceut, E Hanover, NJ USA

[17] Univ Leipzig, D-04109 Leipzig, Germany

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Safety and Efficacy of Ruxolitinib in an 1869-Patient Cohort of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis
Tavares, Renato
Palumbo, Giuseppe A.
Le Coutre, Philipp
Palanciri, Francesca
Al-Ali, Haifa Kathrin
Martino, Bruno
Liberati, Anna Marina
Crass Arich, Jose
Breccia, Massimo
Brittain, David
Foltz, Lynda
Griesshammer, Martin
Raanani, Pia
Gupta, Vikas
Giraldo, Pilar
Chosh, Jagannath
Tannir, Bayane
Ronco, Julian Perez
Vannucchi, Alessandro M.
BLOOD, 2015, 126 (23)
[2] Assessing the Safety and Efficacy of Ruxolitinib in a Multicenter, Open-Label, Expanded-Access Study in Japanese Patients with Myelofibrosis (MF)
Kirito, Keita
Komatsu, Norio
Shimoda, Kazuya
Okada, Hikaru
Amagasaki, Taro
Yonezu, Toshio
Akashi, Koichi
BLOOD, 2015, 126 (23)
[3] SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS WITH INTERMEDIATE-1-RISK MYELOFIBROSIS (MF) FROM AN OPEN-LABEL, MULTICENTER, SINGLE-ARM EXPANDED-ACCESS STUDY
Giraldo, P.
Palandri, F.
Palumbo, G. A.
Zaritskey, A.
Calistri, E.
Skotnicki, A.
Devos, T.
Saavedra, D.
Griesshammer, M.
Al-Ali, H. K.
Tavares, R.
Vannucchi, A. M.
Gupta, V.
Raanani, P.
Tannir, B.
Ghosh, J.
Ronco, J. Perez
Foltz, L.
HAEMATOLOGICA, 2015, 100 : 265 - 265
[4] Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial
Al-Ali, Haifa Kathrin
Griesshammer, Martin
le Coutre, Philipp
Waller, Cornelius F.
Liberati, Anna Marina
Schafhausen, Philippe
Tavares, Renato
Giraldo, Pilar
Foltz, Lynda
Raanani, Pia
Gupta, Vikas
Tannir, Bayane
Ronco, Julian Perez
Ghosh, Jagannath
Martino, Bruno
Vannucchi, Alessandro M.
HAEMATOLOGICA, 2016, 101 (09) : 1065 - 1073
[5] Safety and Efficacy of Ruxolitinib for the Final Enrollment of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (N=2233)
Foltz, Lynda
Palumbo, Giuseppe A.
Martino, Bruno
Palandri, Francesca
Al-Ali, Haifa Kathrin
Liberati, Anna Marina
Le Coutre, Philipp D.
Vannucchi, Alessandro M.
Garcia-Hernandez, Carmen
Tavares, Renato
Griesshammer, Martin
Gupta, Vikas
Raanani, Pia
Giraldo, Pilar
Bouard, Catherine
Ronco, Julian Perez
Khanna, Sadhvi
Zaritskey, Andrey
BLOOD, 2016, 128 (22)
[6] SAFETY AND EFFICACY OF RUXOLITINIB IN PATIENTS WITH DIPSS INTERMEDIATE-1-RISK MYELOFIBROSIS (MF) FROM JUMP: AN OPEN LABEL, MULTICENTER, SINGLE-ARM, EXPANDED-ACCESS STUDY
Passamonti, F.
Zaritskey, A.
Giraldo, P.
Liberati, A. M.
Niederwieser, D.
Palandri, F.
Raanani, P.
Griesshammer, M.
Vannucchi, A. M.
Al-Ali, H. K.
Gupta, V.
Martino, B.
Foltz, L.
Ronco, J. Perez
Ghosh, J.
Bouard, C.
Tavares, R.
HAEMATOLOGICA, 2016, 101 : 93 - 93
[7] Safety and Efficacy of Ruxolitinib Retreatment after Treatment Interruption in Patients Enrolled in an Open-Label, Multicenter, Expanded-Access Study in Myelofibrosis
Gupta, Vikas
Tavares, Renato S.
Griesshammer, Martin
Foltz, Lynda M.
Raanani, Pia
Giraldo, Pilar
Al-Ali, Haifa Kathrin
Martino, Bruno
Tannir, Bayane
Ronco, Julian Perez
Ghosh, Jagannath
Vannucchi, Alessandro M.
BLOOD, 2014, 124 (21)
[8] ASSESSING THE SAFETY AND EFFICACY OF RUXOLITINIB IN AN OPEN-LABEL, MULTICENTER, EXPANDED- ACCESS STUDY IN PATIENTS WITH MYELOFIBROSIS: A 520-PATIENT UPDATE
Al-Ali, H. K.
Le Coutre, P.
Schlag, R.
Griesshammer, M.
Tavares, R.
Martino, B.
Vannucchi, A. M.
Castellano, P. G.
Foltz, L.
Raanani, P.
Tannir, B.
Ghosh, J.
Ronco, J. P.
Gupta, V.
HAEMATOLOGICA, 2014, 99 : 529 - 530
[9] Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
Fleseriu, Maria
Iweha, Chioma
Salgado, Luiz
Mazzuco, Tania Longo
Campigotto, Federico
Maamaris, Ricardo
Limumpornpetch, Padiporn
FRONTIERS IN ENDOCRINOLOGY, 2019, 10
[10] Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study
Zhang, Yi
Zhou, Hu
Duan, Minghui
Gao, Sujun
He, Guangsheng
Jing, Hongmei
Li, Junmin
Ma, Liangming
Zhu, Huanling
Chang, Chunkang
Du, Xin
Hong, Mei
Li, Xin
Liu, Qingchi
Wang, Wei
Xu, Na
Yang, Haiping
Lu, Binhua
Yin, Hewen
Wu, Liqing
Suo, Shanshan
Zhao, Qingwei
Xiao, Zhijian
Jin, Jie
AMERICAN JOURNAL OF HEMATOLOGY, 2023, : 1588 - 1597

← 1 2 3 4 5 →